Moderna (MRNA) Inventory (2020 - 2026)
Moderna (MRNA) posted quarterly Inventory of $280.0 million for Q2 2026, up 16.67% year-over-year from $240.0 million in Q2 2025, and up 91.78% on a QoQ basis from $146.0 million in Q1 2026.
Moderna (MRNA) Inventory (2020 - 2026) Analysis & Trends
Moderna has reported Inventory for 7 years, with the latest figure at $280.0 million in Q2 2026.
- Inventory for Q2 2026 came in at $280.0 million, up 16.67% year-over-year; the trailing twelve-month figure through Jun 2026 was $280.0 million (up 16.67% YoY), and the FY2025 annual result was $153.0 million, up 30.77% from the prior year.
- Inventory improved to $280.0 million in Q2 2026, from $146.0 million in the prior quarter.
- Over five years, Inventory peaked at $2.1 billion in Q3 2022 and troughed at $117.0 million in Q4 2024.
- A 5-year average of $640.4 million and a median of $365.5 million in 2024 frame the typical range for Inventory.
- The widest annual swing landed in 2022, when Inventory surged 293.12%; it then plunged 78.71% in 2023.
- A 5-year view of Inventory shows it stood at $949.0 million in 2022, then tumbled by 78.71% to $202.0 million in 2023, then plunged by 42.08% to $117.0 million in 2024, then soared by 30.77% to $153.0 million in 2025, then surged by 83.01% to $280.0 million in 2026.
- Per Business Quant data, the three most recent Inventory figures were $280.0 million in Q2 2026, $146.0 million in Q1 2026, and $153.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 371.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 732.60 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 358,916.96 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 97.11 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 142.38 Mn |
| 10 | Moderna | 25.26 Bn | 20.13 Bn | 52.00 Mn | 280.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 280.00 Mn |
| Mar 31, 2026 | 146.00 Mn |
| Dec 31, 2025 | 153.00 Mn |
| Sep 30, 2025 | 332.00 Mn |
| Jun 30, 2025 | 240.00 Mn |
| Mar 31, 2025 | 128.00 Mn |
| Dec 31, 2024 | 117.00 Mn |
| Sep 30, 2024 | 412.00 Mn |
| Jun 30, 2024 | 399.00 Mn |
| Mar 31, 2024 | 295.00 Mn |
| Dec 31, 2023 | 202.00 Mn |
| Sep 30, 2023 | 487.00 Mn |
| Jun 30, 2023 | 715.00 Mn |
| Mar 31, 2023 | 732.00 Mn |
| Dec 31, 2022 | 949.00 Mn |
| Sep 30, 2022 | 2.08 Bn |
| Jun 30, 2022 | 1.92 Bn |
| Mar 31, 2022 | 1.94 Bn |
| Dec 31, 2021 | 1.44 Bn |
| Sep 30, 2021 | 965.00 Mn |